Peter Bader

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Venues

Bone marrow transplantation

Cells

Blood advances

Leukemia

University of Frankfurt

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Frankfurt Oct 01 2004

Germany

Prof. Dr. ; Head of Department :: Stem Cell Transplantation

Publications

Barbara Meissner, Peter Lang, Peter Bader, Manfred Hoenig, Ingo Müller, Richard P Meisel, Johann Greil, Martin G Sauer, Markus Metzler, Selim Corbacioglu, Birgit Burkhardt, Matthias Wölfl, Brigitte Strahm, Kinan Kafa, Oliver Basu, Holger N Lode, Bernd Gruhn, Holger Cario, Ann-Kathrin Ozga, Martin Zimmermann, Andrea Jarisch, Rita Beier
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression. Bone marrow transplantation 59 (5) (2024)
Barbara Meissner, Peter Lang, Peter Bader, Manfred Hoenig, Ingo Müller, Richard P Meisel, Johann Greil, Martin G Sauer, Markus Metzler, Selim Corbacioglu, Birgit Burkhardt, Matthias Wölfl, Brigitte Strahm, Kinan Kafa, Oliver Basu, Holger N Lode, Bernd Gruhn, Holger Cario, Ann-Kathrin Ozga, Martin Zimmermann, Andrea Jarisch, Rita Beier
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression. Bone marrow transplantation (2024)
Barbara Meissner, Peter Lang, Peter Bader, Manfred Hoenig, Ingo Müller, Richard P Meisel, Johann Greil, Martin G Sauer, Markus Metzler, Selim Corbacioglu, Birgit Burkhardt, Matthias Wölfl, Brigitte Strahm, Kinan Kafa, Oliver Basu, Holger N Lode, Bernd Gruhn, Holger Cario, Ann-Kathrin Ozga, Martin Zimmermann, Andrea Jarisch, Rita Beier
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression. Bone marrow transplantation 59 (5) (2024)
Barbara Meissner, Peter Lang, Peter Bader, Manfred Hoenig, Ingo Müller, Richard P Meisel, Johann Greil, Martin G Sauer, Markus Metzler, Selim Corbacioglu, Birgit Burkhardt, Matthias Wölfl, Brigitte Strahm, Kinan Kafa, Oliver Basu, Holger N Lode, Bernd Gruhn, Holger Cario, Ann-Kathrin Ozga, Martin Zimmermann, Andrea Jarisch, Rita Beier
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression. Bone marrow transplantation 59 (5) (2024)
Barbara Meissner, Peter Lang, Peter Bader, Manfred Hoenig, Ingo Müller, Richard P Meisel, Johann Greil, Martin G Sauer, Markus Metzler, Selim Corbacioglu, Birgit Burkhardt, Matthias Wölfl, Brigitte Strahm, Kinan Kafa, Oliver Basu, Holger N Lode, Bernd Gruhn, Holger Cario, Ann-Kathrin Ozga, Martin Zimmermann, Andrea Jarisch, Rita Beier
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression. Bone marrow transplantation 59 (5) (2024)
Peter Bader, Ulrike Poetschger, Jean-Hugues Dalle, Laura M Moser, Adriana Cristina Balduzzi, Marc Ansari, Jochen Buechner, Tayfun Güngör, Marianne Ifversen, Gergely Kriván, Herbert Pichler, Marleen Renard, Raquel Staciuk, Petr Sedláček, Jerry Stein, Jan Robert Heusel, Tony Truong, Jacek Wachowiak, M Akif Yeşilipek, Franco Locatelli, Christina Peters
Low rate of nonrelapse mortality in under 4-year-olds with ALL given chemo-conditioning for HSCT: Phase III FORUM study. Blood advances (2023)
Karl-Walter Sykora, Rita Beier, Ansgar S Schulz, Simone Cesaro, Johann Greil, Jolanta Gozdzik, Petr Sedlacek, Peter Bader, Johannes Schulte, Marco Zecca, Franco Locatelli, Bernd Gruhn, Dirk Reinhardt, Jan Styczyński, Simona Piras, Franca Fagioli, Sonia Bonanomi, Maurizio Caniglia, Xieran Li, Joachim Baumgart, Jochen Kehne, Monika Mielcarek-Siedziuk, Krzysztof Kalwak
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial. Bone marrow transplantation (2023)
Peter Bader
Allo or auto CAR-T cells for refractory BCP-ALL? Blood 142 (2) (2023)
Natascha Piede, Melanie Bremm, Anne Farken, Lisa-Marie Pfeffermann, Claudia Cappel, Halvard Bonig, Theres Fingerhut, Laura Puth, Kathrin Vogelsang, Andreas Peinelt, Rolf Marschalek, Matthias Müller, Peter Bader, Zyrafete Kuçi, Selim Kuçi, Sabine Huenecke
Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation. Cells 12 (6) (2023)
Natascha Piede, Melanie Bremm, Anne Farken, Lisa-Marie Pfeffermann, Claudia Cappel, Halvard Bonig, Theres Fingerhut, Laura Puth, Kathrin Vogelsang, Andreas Peinelt, Rolf Marschalek, Matthias Müller, Peter Bader, Zyrafete Kuçi, Selim Kuçi, Sabine Huenecke
Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation. Cells 12 (6) (2023)
Diana Averbuch, Rafael De la Cámara LLanzá, Gloria Tridello, Nina Simone Knelange, Tatiana Alexandrovna Bykova, Marianne Ifversen, Veronika Dobsinska, Mouhab F Ayas, Amir Ali Hamidieh, Herbert Pichler, Pérez-Martínez Antonio, Simone Cesaro, Mikael Sundin, Isabel Badell, Peter Bader, Jan-Erik Johansson, Oana Mirci-Danicar, Petr Sedláček, Catherine Paillard, Brenda Gibson, Sarah Lawson, Nicolaus M Kröger, Selim Corbacioglu, Malgorzata Mikulska, José Luis Piñana, Jan Styczyński, Qamar-Un-Nisa Chaudhry
Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study. Bone marrow transplantation (2023)
Florent Malard, Florent Malard, Ahmed S Al Askar, Mahmoud Aljurf, Mutlu Arat, Peter Bader, Fréderic Baron, Ali Bazarbachi, Didier Blaise, Eolia Brissot, Fabio Ciceri, Selim Corbacioglu, Jean-Hugues Dalle, Fiona Dignan, Anne Huynh, Michelle Kenyon, Arnon Nagler, Antonio Pagliuca, Zinaida Perić, Paul Gerard Richardson, Annalisa Ruggeri, Tapani Ruutu, Ibrahim Yakoub Agha, Rafael F Duarte, Enric Carreras
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone marrow transplantation (2023)
Florent Malard, Florent Malard, Ahmed S Al Askar, Mahmoud Aljurf, Mutlu Arat, Peter Bader, Fréderic Baron, Ali Bazarbachi, Didier Blaise, Eolia Brissot, Fabio Ciceri, Selim Corbacioglu, Jean-Hugues Dalle, Fiona Dignan, Anne Huynh, Michelle Kenyon, Arnon Nagler, Antonio Pagliuca, Zinaida Perić, Paul Gerard Richardson, Annalisa Ruggeri, Tapani Ruutu, Ibrahim Yakoub Agha, Rafael F Duarte, Enric Carreras
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone marrow transplantation (2023)
Peter Bader, Claudia Rossig, Martin Hutter, Francis Ayuketang Ayuk, Claudia D Baldus, Veit L Bücklein, Halvard Bonig, Gunnar Cario, Hermann Einsele, Udo Holtick, Christian Koenecke, Shahrzad Bakhtiar, Annette Künkele, Richard P Meisel, Fabian Mueller, Ingo Müller, Olaf Penack, Eva Rettinger, Martin G Sauer, Paul-Gerhardt Schlegel, Jan Soerensen, Arend von Stackelberg, Brigitte Strahm, Tobias Feuchtinger, Julia Hauer, Andrea Jarisch
CD19-CAR-T cells are an effective therapy of post-transplant relapse in B- ALL patients: Real-World Data from Germany. Blood advances (2023)
Natascha Piede, Melanie Bremm, Anne Farken, Lisa-Marie Pfeffermann, Claudia Cappel, Halvard Bonig, Theres Fingerhut, Laura Puth, Kathrin Vogelsang, Andreas Peinelt, Rolf Marschalek, Matthias Müller, Peter Bader, Zyrafete Kuçi, Selim Kuçi, Sabine Huenecke
Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation. Cells 12 (6) (2023)
Diana Averbuch, Rafael De la Cámara LLanzá, Gloria Tridello, Nina Simone Knelange, Tatiana Alexandrovna Bykova, Marianne Ifversen, Veronika Dobsinska, Mouhab F Ayas, Amir Ali Hamidieh, Herbert Pichler, Pérez-Martínez Antonio, Simone Cesaro, Mikael Sundin, Isabel Badell, Peter Bader, Jan-Erik Johansson, Oana Mirci-Danicar, Petr Sedláček, Catherine Paillard, Brenda Gibson, Sarah Lawson, Nicolaus M Kröger, Selim Corbacioglu, Malgorzata Mikulska, José Luis Piñana, Jan Styczyński, Qamar-Un-Nisa Chaudhry
Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study. Bone marrow transplantation (2023)
Florent Malard, Florent Malard, Ahmed S Al Askar, Mahmoud Aljurf, Mutlu Arat, Peter Bader, Fréderic Baron, Ali Bazarbachi, Didier Blaise, Eolia Brissot, Fabio Ciceri, Selim Corbacioglu, Jean-Hugues Dalle, Fiona Dignan, Anne Huynh, Michelle Kenyon, Arnon Nagler, Antonio Pagliuca, Zinaida Perić, Paul Gerard Richardson, Annalisa Ruggeri, Tapani Ruutu, Ibrahim Yakoub Agha, Rafael F Duarte, Enric Carreras
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone marrow transplantation (2023)
Julia Fekadu, Ute Modlich, Peter Bader, Shahrzad Bakhtiar
Understanding the Role of LFA-1 in Leukocyte Adhesion Deficiency Type I (LAD I): Moving towards Inflammation? International journal of molecular sciences 23 (7) (2022)
Franco Locatelli, Gerhard Zugmaier, Noemi Mergen, Peter Bader, Sima Jeha, Paul-Gerhardt Schlegel, Jean-Pierre Bourquin, Rupert Handgretinger, Benoit Brethon, Claudia Rössig, William N Kormany, Puneeth Viswagnachar, Christiane Chen-Santel
Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis. Blood advances 6 (3) (2022)
Daphna Hutt, Eugenia Trigoso Arjona, Hilda Mekelenkamp, Jacques-Emmanuel Galimard, Anne Kozijn, Teija Schröder, Marjola Gjergji, Arnaud Dalissier, Sarah J Liptrott, John Murray, Michelle Kenyon, J P J van Gestel, Selim Corbacioglu, Peter Bader, null null, null null
Safe transfer of pediatric patients from hematopoietic stem cell transplant unit into the pediatric intensive care unit: views of nurses and physicians. Bone marrow transplantation 57 (5) (2022)
Elad Jacoby, Sara Ghorashian, Britta Vormoor, Barbara De Moerloose, Nicole Bodmer, Olga Molostova, Asaf D Yanir, Jochen Buechner, Ronit Elhasid, Bella Bielorai, Srdan Rogosic, Marie-Emilie Dourthe, Mikhail A Maschan, Claudia Rossig, Amos Toren, Arend von Stackelberg, Franco Locatelli, Peter Bader, Martin Zimmermann, Jean Pierre Bourquin, Andre Baruchel
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study. Leukemia 36 (6) (2022)
Daniela Andrea Weber, Markus Weber, Elisabeth Meedt, Sakhila Ghimire, Daniel Wolff, Matthias Edinger, Hendrik Poeck, Andreas Hiergeist, Andre Gessner, Francis Ayuketang Ayuk, Wolf Roesler, Matthias Wolfl, Sabrina Kraus, Robert Zeiser, Hannah Bertrand, Peter Bader, Evelyn Ullrich, Matthias Eder, Sigrun Gleich, Rachel Young, Wolfgang Herr, John E Levine, James Lm Ferrara, Ernst Holler
Reg3α levels at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use. Blood advances (2022)
Anna Eichinger, Ulrike Poetschger, Evgenia Glogova, Peter Bader, Oliver Basu, Rita Beier, Birgit Burkhardt, Carl-Friedrich Classen, Alexander Claviez, Selim Corbacioglu, Hedwig E Deubzer, Johann Greil, Bernd Gruhn, Tayfun Güngör, Kinan Kafa, Jörn-Sven Kühl, Peter Lang, Bjoern Soenke Lange, Richard P Meisel, Ingo Müller, Martin G Sauer, Paul-Gerhardt Schlegel, Ansgar S Schulz, Daniel Stachel, Brigitte Strahm, Angela Wawer, Christina Peters, Michael H Albert
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial. Leukemia 36 (11) (2022)
Theodore W Laetsch, Shannon L Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt, Peter Bader, Andre Baruchel, Michael Boyer, Barbara De Moerloose, Muna Qayed, Jochen Buechner, Michael A Pulsipher, Gary Douglas Myers, Heather E Stefanski, Paul L Martin, Eneida Nemecek, Christina Peters, Gregory Yanik, Seong Lin Khaw, Kara L Davis, Joerg Krueger, Adriana Cristina Balduzzi, Nicolas Boissel, Ranjan Tiwari, Darragh O'Donovan, Stephan A Grupp
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Valeria Ceolin, Erica Brivio, Harm van Tinteren, Susan R Rheingold, Allison Leahy, Britta Vormoor, Maureen M O'Brien, Jeremy D Rubinstein, Krzysztof Kalwak, Barbara De Moerloose, Elad Jacoby, Peter Bader, Monica Lopez-Duarte, Bianca Frederika Goemans, Franco Locatelli, Peter Hoogerbrugge, Friso G J Calkoen, Christian Michel Zwaan
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia. Leukemia (2022)
Liudmila Leppik, Anna Gempp, Zyrafete Kuçi, Selim Kuçi, Peter Bader, Halvard Bönig, Ingo Marzi, Dirk Henrich
A New Perspective for Bone Tissue Engineering: Human Mesenchymal Stromal Cells Well-Survive Cryopreservation on β-TCP Scaffold and Show Increased Ability for Osteogenic Differentiation. International journal of molecular sciences 23 (3) (2022)
Deborah S Hooker, Kristin Grabe-Heyne, Christof Henne, Peter Bader, Mondher Toumi, Stephen J Furniss
Improved Therapeutic Approaches are Needed to Manage Graft-versus-Host Disease. Clinical drug investigation 41 (11) (2021)
Leonie D H Gossel, Catrin Heim, Lisa-Marie Pfeffermann, Laura M Moser, Halvard B Bönig, Thomas E Klingebiel, Peter Bader, Winfried S Wels, Michael Merker, Eva Rettinger
Retargeting of NK-92 Cells against High-Risk Rhabdomyosarcomas by Means of an ERBB2 (HER2/Neu)-Specific Chimeric Antigen Receptor. Cancers 13 (6) (2021)
Hilda Mekelenkamp, Teija Schröder, Eugenia Trigoso, Daphna Hutt, Jacques-Emmanuel Galimard, Anne Kozijn, Arnaud Dalissier, Marjola Gjergji, Sarah Liptrott, Michelle Kenyon, John Murray, Selim Corbacioglu, Peter Bader, null On Behalf Of The Ebmt-Nurses Group, null Paediatric Diseases Working Party
Specialized Pediatric Palliative Care Services in Pediatric Hematopoietic Stem Cell Transplant Centers. Children (Basel, Switzerland) 8 (8) (2021)
Vanessa Neef, Elke Schmitt, Peter Bader, Frank Zierfuß, Gudrun Hintereder, Andrea U Steinbicker, Kai Zacharowski, Florian Piekarski
The Reticulocyte Hemoglobin Equivalent as a Screening Marker for Iron Deficiency and Iron Deficiency Anemia in Children. Journal of clinical medicine 10 (16) (2021)
Patrick C Baer, Julia Sann, Ruth Pia Duecker, Evelyn Ullrich, Helmut Geiger, Peter Bader, Stefan Zielen, Ralf Schubert
Tracking of Infused Mesenchymal Stem Cells in Injured Pulmonary Tissue in Atm-Deficient Mice. Cells 9 (6) (2020)
Halvard Bonig, Zyrafete Kuçi, Selim Kuçi, Shahrzad Bakhtiar, Oliver Basu, Gesine Bug, Mike Dennis, Johann Greil, Aniko Barta, Krisztián M Kállay, Peter Lang, Giovanna Lucchini, Raj Pol, Ansgar S Schulz, Karl-Walter Sykora, Irene Teichert von Luettichau, Grit Herter-Sprie, Mohammad Ashab Uddin, Phil Jenkin, Abdulrahman Alsultan, Jochen Buechner, Jerry Stein, Agnes Kelemen, Andrea Jarisch, Jan Soerensen, Emilia Salzmann-Manrique, Martin Hutter, Richard Schäfer, Erhard Seifried, Shankara Paneesha, Igor Novitzky-Basso, Aharon Gefen, Neta Nevo, Gernot Beutel, Paul-Gerhardt Schlegel, Thomas Klingebiel, Peter Bader
Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients. Cells 8 (12) (2019)

Peter Bader.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Peter Bader